132 related articles for article (PubMed ID: 8022146)
1. [Flare response on bone scintigraphy in metastatic prostate cancer].
Aizawa T; Tochimoto M; Ito T; Tsujino S; Akiyama A; Namiki K; Miki M; Ueda M
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):815-8. PubMed ID: 8022146
[TBL] [Abstract][Full Text] [Related]
2. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.
Cook GJ; Venkitaraman R; Sohaib AS; Lewington VJ; Chua SC; Huddart RA; Parker CC; Dearnaley DD; Horwich A
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):7-13. PubMed ID: 20697891
[TBL] [Abstract][Full Text] [Related]
4. The CT flare response of metastatic bone disease in prostate cancer.
Messiou C; Cook G; Reid AH; Attard G; Dearnaley D; de Bono JS; de Souza NM
Acta Radiol; 2011 Jun; 52(5):557-61. PubMed ID: 21498309
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between extent of bone metastases and effect of endocrine therapy evaluated with bone scintigraphy in stage D2 prostatic cancer].
Tanaka M; Murakami S; Akimoto S; Masai M; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1036-42. PubMed ID: 1507721
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. [Paget's disease mimicking metastatic prostate cancer on bone scan image : a case report].
Fukushi K; Koie T; Yamamoto H; Okamoto A; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
Hinyokika Kiyo; 2013 Apr; 59(4):247-50. PubMed ID: 23635462
[TBL] [Abstract][Full Text] [Related]
8. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
[TBL] [Abstract][Full Text] [Related]
9. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
[TBL] [Abstract][Full Text] [Related]
10. [Relation between serum PAP (prostate acid phosphatase) and bone scintigraphy in prostatic cancer].
Aizawa T; Itoh T; Tsujino S; Namiki K; Miki M
Kaku Igaku; 1992 Nov; 29(11):1277-83. PubMed ID: 1484418
[TBL] [Abstract][Full Text] [Related]
11. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
Liewendahl K; Alfthan O; Ikonen T; Ruutu M; Rannikko S
Scand J Urol Nephrol; 1984; 18(3):181-5. PubMed ID: 6494827
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
[TBL] [Abstract][Full Text] [Related]
13. Flare phenomenon following gefitinib treatment of lung adenocarcinoma with bone metastasis.
Hashisako M; Wakamatsu K; Ikegame S; Kumazoe H; Nagata N; Kajiki A
Tohoku J Exp Med; 2012 Oct; 228(2):163-8. PubMed ID: 23036980
[TBL] [Abstract][Full Text] [Related]
14. How significant are serial bone scans in monitoring advanced prostatic cancer?
Tekgül S; Ozen H; Ozyavuz R; Bakkaloğlu M; Remzi D
Int Urol Nephrol; 1995; 27(1):87-91. PubMed ID: 7615375
[TBL] [Abstract][Full Text] [Related]
15. [A patient with multiple bone metastases from gastric cancer after an 8-year disease-free interval following gastrectomy].
Takemura M; Osugi H; Lee S; Nishikawa T; Fukuhara K; Iwasaki H
Gan To Kagaku Ryoho; 2005 Apr; 32(4):515-7. PubMed ID: 15853219
[TBL] [Abstract][Full Text] [Related]
16. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival].
Lobo G; Ladrón de Guevara D; Salgado G; Donoso G; Bagus F
Rev Med Chil; 1999 Feb; 127(2):181-8. PubMed ID: 10436698
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
Kageyama Y; Kihara K; Kamata S; Nagahama K; Yonese J; Fukuda H; Tosaka A; Nagamatsu H; Ishizaka K; Tsujii T; Kitahara S; Morita T; Oshima H
Hinyokika Kiyo; 1996 Mar; 42(3):197-9. PubMed ID: 8619388
[TBL] [Abstract][Full Text] [Related]
18. [The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Furukawa Y; Tanaka H
Kaku Igaku; 1994 Jun; 31(6):541-50. PubMed ID: 7520953
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow scintigraphy in the diagnosis of bone metastasis in prostate cancer.
Fuse H; Nagakawa O; Seto H; Katayama T
Int Urol Nephrol; 1994; 26(1):53-61. PubMed ID: 8026923
[TBL] [Abstract][Full Text] [Related]
20. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
